NL-OMON26180
Completed
未知
Tumor markers in diagnostics and follow up of lung carcinoma
Catharina Ziekenhuis Eindhoven, NWO, Catharina Onderzoeksfonds, Roche Diagnostics Nederland0 sites1,500 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Catharina Ziekenhuis Eindhoven, NWO, Catharina Onderzoeksfonds, Roche Diagnostics Nederland
- Enrollment
- 1500
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
DOI: 10.1016/j.jmoldx.2019.05.003 DOI: 10.18632/oncotarget.27664 DOI: 10.1016/j.jmoldx.2021.01.003 DOI: 10.1016/j.ctarc.2021.100410 DOI: 10.1016/j.ctarc.2021.100449
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patiënten met verdenking op long kanker |
Exclusion Criteria
- •\- Leeftijd jonger dan 18 jaar |
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Tumormarkers in diagnostics and follow up of lungcarcinomaNL-OMON47860Catharina-ziekenhuis1,500
Completed
Not Applicable
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsLung CancerNCT00899028Vanderbilt University Medical Center689
Completed
Not Applicable
Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung CancerLung CancerNCT00213733University Hospital, Strasbourg, France150
Terminated
Not Applicable
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) NetworkNon-small Cell Lung Cancer MetastaticSmall Cell Lung CarcinomaNCT01574300Addario Lung Cancer Medical Institute136
Active, not recruiting
Not Applicable
Biomarkers for Diagnosis of Lung NodulesLung AbscessNCT01085864University of Colorado, Denver550